All the news Showing 10 of 83 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Antibiotic prophylaxis reduces the risk of short-term death in people with decompensated cirrhosis Keith Alcorn / 20 April 2017 Long-term prophylaxis with the antibiotic norfloxacin significantly reduced the incidence of deaths in people with decompensated cirrhosis over a six-month follow-up period, a French randomised trial reported today at the International Liver Congress ... Statins reduce risk of decompensation for people with HCV- and HBV-related cirrhosis Michael Carter / 18 April 2017 Treatment with statins reduces the risk of decompensated liver disease for people with cirrhosis caused by hepatitis B virus (HBV) and hepatitis C virus (HCV), investigators from Taiwan report in the online edition ... Co-infection with HCV increases cancer risk for people with HIV Michael Carter / 28 March 2017 People with HIV and hepatitis C virus (HCV) co-infection have an increased risk of non-AIDS-defining cancers compared to people with HIV mono-infection, investigators from Spain report in the online edition of AIDS. Even ... Results of US research suggest all people with chronic HCV need treatment to reduce mortality risk Michael Carter / 22 March 2017 All people with chronic hepatitis C virus (HCV) infection should start therapy with direct-acting antivirals, research published in the online edition of Clinical Infectious Diseases suggests. Investigators from the United States found that individuals ... Two-thirds of people with HIV/HCV co-infection in Southeast Asia in need of HCV therapy Michael Carter / 15 March 2017 Almost two-thirds of people with HIV/hepatitis C virus (HCV) co-infection in Asia are in need of HCV therapy with a fifth of people having cirrhosis, investigators report in the Journal of Viral ... HCV infection increases risk of several non-liver-related cancers in elderly people Michael Carter / 09 March 2017 Hepatitis C virus (HCV) infection is associated with a range of non-liver-related cancers, investigators from the United States report in Cancer. The study population comprised over 1.6m elderly people with cancer and ... DAA therapy cures most people with HIV/HCV co-infection with decompensated cirrhosis or liver transplants Liz Highleyman / 07 March 2017 People with HIV/hepatitis C virus (HCV) co-infection with liver cirrhosis or liver failure, and those who received liver transplants, saw high rates of sustained virological response using interferon-free direct-acting antiviral (DAA) therapy for ... Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer? Liz Highleyman / 27 February 2017 People with HIV and hepatitis C virus (HCV) co-infection who are successfully treated for hepatitis C using interferon-free direct-acting antiviral (DAA) therapy do not appear to have an increased likelihood of developing hepatocellular ... Liver cirrhosis and decompensation still on the rise among people with hepatitis C Liz Highleyman / 18 January 2017 Complications of advanced liver disease including cirrhosis and hepatic decompensation have risen over the past decade among people with chronic hepatitis C, according to study findings presented at the 2016 ... Nivolumab demonstrates good safety and promising response rates in liver cancer study Liz Highleyman / 03 January 2017 Nivolumab (Opdivo), an antibody that blocks the PD-1 receptor and restores T-cell anti-tumour activity, appeared safe and was associated with disease control and stabilisation in a phase 1/2 study of people with hepatocellular ... ← Prev1...23456...9Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive